Answer
Two AOMT studies found no or negligible plasma levels of ciprofloxacin and/or fluocinolone acetonide, indicating that Cetraxal Plus ear administration is unlikely to produce pharmacokinetically or clinically relevant systemic levels.
Sources for this answer
- Cetraxal Plus 3 mg/ml + 0.25 mg/ml ear drops solution in single-dose containerAspire Pharma Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 3Document updated
Sources checked